1
|
Yan T, Weng F, Ming Y, Zhu S, Zhu M, Wang C, Guo C, Zhu K. Luminescence Probes in Bio-Applications: From Principle to Practice. BIOSENSORS 2024; 14:333. [PMID: 39056609 PMCID: PMC11274413 DOI: 10.3390/bios14070333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/05/2024] [Revised: 07/03/2024] [Accepted: 07/04/2024] [Indexed: 07/28/2024]
Abstract
Bioanalysis based on optical imaging has gained significant progress in the last few decades. Luminescence probes are capable of detecting, monitoring, and tracing particular biomolecules in complex biological systems to figure out the roles of these molecules in organisms. Considering the rapid development of luminescence probes for bio-applications and their promising future, we have attempted to explore the working principles and recent advances in bio-applications of luminescence probes, in the hope of helping readers gain a detailed understanding of luminescence probes developed in recent years. In this review, we first focus on the current widely used luminescence probes, including fluorescence probes, bioluminescence probes, chemiluminescence probes, afterglow probes, photoacoustic probes, and Cerenkov luminescence probes. The working principles for each type of luminescence probe are concisely described and the bio-application of the luminescence probes is summarized by category, including metal ions detection, secretion detection, imaging, and therapy.
Collapse
Affiliation(s)
| | | | | | | | | | - Chunsheng Wang
- Department of Cardiovascular Surgery, Zhongshan Hospital Fudan University, Shanghai 200032, China; (T.Y.); (F.W.); (Y.M.); (S.Z.); (M.Z.)
| | - Changfa Guo
- Department of Cardiovascular Surgery, Zhongshan Hospital Fudan University, Shanghai 200032, China; (T.Y.); (F.W.); (Y.M.); (S.Z.); (M.Z.)
| | - Kai Zhu
- Department of Cardiovascular Surgery, Zhongshan Hospital Fudan University, Shanghai 200032, China; (T.Y.); (F.W.); (Y.M.); (S.Z.); (M.Z.)
| |
Collapse
|
2
|
Yuan M, Fang X, Liu J, Yang K, Xiao S, Yang S, Du W, Song J. NIR-II Self-Luminous Molecular Probe for In Vivo Inflammation Tracking and Cancer PDT Effect Self-Evaluating. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2023; 19:e2206666. [PMID: 36534901 DOI: 10.1002/smll.202206666] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2022] [Revised: 11/27/2022] [Indexed: 06/17/2023]
Abstract
Optical imaging in the second near-infrared (NIR-II, 900-1700 nm) window has been extensively investigated for bioimaging. However, a strong autofluorescence background from real-time excitation light significantly reduces the images' quality of NIR-II fluorescence (FL) imaging. To resolve this issue, a NIR-II self-luminous small molecule (CLPD) based on bioluminescence (BL) resonance energy transfer (BRET) mechanism is first developed. The reactive oxygen species (ROS) can trigger NIR-II BL and reduce the NIR-II FL signals of the CLPD simultaneously, enabling ROS-correlated ratiometric BL/FL imaging. CLPD is used for high-contrast NIR-II BL imaging of osteoarthritis as well as guiding the treatment process by ratiometric BL/FL imaging. Moreover, CLPD is applied for NIR-II BL imaging of tumor triggered by the generated ROS during PDT. A correlation between the ratiometric NIR-II BL/FL signal and tumor size is constructed, providing a trustworthy tool for early assessment of PDT effect. Overall, this study presents a novel NIR-II self-luminous small molecular probe for in vivo imaging and provides a strategy for design a self-evaluation system of therapeutic effect.
Collapse
Affiliation(s)
- Meng Yuan
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| | - Xiao Fang
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| | - Jianyong Liu
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| | - Kaiqiong Yang
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| | - Shenggan Xiao
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| | - Sheng Yang
- Departments of Oncology Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, P.R. China
| | - Wei Du
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| | - Jibin Song
- College of Chemistry, Fuzhou University, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China, Fuzhou, 350108, P. R. China
| |
Collapse
|
3
|
Zhang L, Ying W, Sheng Z, Lv L, Gao J, Xue Y, Liu L. Bioluminescence imaging of fibroblast activation protein-alpha in vivo and human plasma with highly sensitive probe. Anal Biochem 2022; 655:114859. [PMID: 35988797 DOI: 10.1016/j.ab.2022.114859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 08/09/2022] [Indexed: 11/01/2022]
Abstract
Fibroblast activation protein-alpha (FAPα) has emerged as a biomarker of tumor stromal fibroblasts. FAP was overexpressed in stromal fibroblasts of human malignancies and positively correlated with the depth of tumor invasion, lymphatic metastasis, distant metastases, high TNM stage and poor prognosis. However, the circulating FAP levels in the plasma of gastric cancer patients and the relationship between FAP levels and gastric cancer remain unknown. Moreover, probes with super selectivity, extremely high sensitivity, and excellent performance in quantitative detection are still lacking. Herein, we developed the bioluminescent probe BL-FAP for sensitive detection and imaging of endogenous FAP in gastric cancer cells and tissues and plasma from gastric cancer patients. The probe exhibited the high signal-to-noise ratio (15000∼fold), the excellent selectivity (FAP/DPP IV ratio and FAP/PREP ratio = 50000∼ fold), and the high sensitivity (18.1 pg/mL). BL-FAP facilitates monitoring of endogenous FAP in living cells and nude mice bearing MGC-803-luc tumors. More importantly, this probe was successfully applied to the measurement of FAP activity levels in plasma from gastric cancer patients for the first time. A significant enhancement in FAP levels was observed in patients with gastric cancer, suggesting that the FAP level may be a potential diagnostic parameter for gastric cancer.
Collapse
Affiliation(s)
- Ling Zhang
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China; State Key Laboratory of Coordination Chemistry, Nanjing University, Nanjing, 210023, PR China.
| | - Weiwu Ying
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China
| | - Zhijia Sheng
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China
| | - Li Lv
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China
| | - Jian Gao
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China
| | - Yunsheng Xue
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China
| | - Ling Liu
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, Xuzhou, 221002, PR China
| |
Collapse
|
4
|
Solvent polarity influence on chemiexcitation efficiency of inter and intramolecular electron-transfer catalyzed chemiluminescence. J Photochem Photobiol A Chem 2022. [DOI: 10.1016/j.jphotochem.2022.114161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
5
|
Shi X, Deng Y, Liu X, Gao G, Wang R, Liang G. An aminopeptidase N-activatable chemiluminescence probe for image-guided surgery and metastasis tracking of tumor. Biosens Bioelectron 2022; 208:114212. [DOI: 10.1016/j.bios.2022.114212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Revised: 03/17/2022] [Accepted: 03/21/2022] [Indexed: 11/25/2022]
|
6
|
Kagalwala HN, Reeves RT, Lippert AR. Chemiluminescent spiroadamantane-1,2-dioxetanes: Recent advances in molecular imaging and biomarker detection. Curr Opin Chem Biol 2022; 68:102134. [DOI: 10.1016/j.cbpa.2022.102134] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Revised: 02/19/2022] [Accepted: 02/22/2022] [Indexed: 12/31/2022]
|
7
|
Wang B, Chen Z, Cen X, Liang Y, Tan L, Liang E, Zheng L, Zheng Y, Zhan Z, Cheng K. Highly Selective and Sensitive Chemiluminescent Probe for Leucine Aminopeptidase Detection in Vitro, in Vivo and in human Liver Cancer Tissue. Chem Sci 2022; 13:2324-2330. [PMID: 35310505 PMCID: PMC8864696 DOI: 10.1039/d1sc06528a] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Accepted: 01/17/2022] [Indexed: 12/24/2022] Open
Abstract
Leucine aminopeptidase (LAP) is involved in tumor cell proliferation, invasion, and angiogenesis, and is a well-known tumor marker. In recent years, chemiluminescence has been widely used in the field of biological imaging, due to it resulting in a high sensitivity and excellent signal-to-noise ratio. Here, we report the design, synthesis, and evaluation of the first LAP-activated chemiluminescent probe for LAP detection and imaging. The probe initially had no chemiluminescence but produced an extremely strong chemiluminescence after the release of the dioxetane intermediate in the presence of LAP. The probe had high selectivity over other proteases and higher signal-to-noise ratios than commercial fluorophores. Real-time imaging results indicated that the chemiluminescence was remarkably enhanced at the mice tumor site after the probe was injected. Furthermore, the chemiluminescence of this probe in the cancerous tissues of patients was obviously improved compared to that of normal tissues. Taken together, this study has developed the first LAP-activable chemiluminescent probe, which could be potentially used in protein detection, disease diagnosis, and drug development. The first chemiluminescent probe for the detection of LAP is described. It shows a highly selective, sensitive and rapid chemiluminescence response for the detection of LAP in vitro and in vivo, and enables the differentiation of liver cancer.![]()
Collapse
Affiliation(s)
- Baoqu Wang
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Zhenzhou Chen
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Xiaohong Cen
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Yuqing Liang
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Liyi Tan
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - En Liang
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Lu Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Yanjun Zheng
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Zhikun Zhan
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
| | - Kui Cheng
- Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 Guangdong Province People's Republic of China
- Department of Musculoskeletal Oncology, The Third Affiliated Hospital of Southern Medical University Guangzhou 510642 Guangdong Province People's Republic of China
| |
Collapse
|